• Caspase-8 Fluorometric Assay Kit Guide

  2026-09-10

  The Caspase-8 Fluorometric Assay Kit uses IETD-AFC cleavage to measure IETD-dependent caspase activity through a fluorescence shift. It supports rapid caspase activity measurement in apoptosis, programmed cell death research, drug screening, and carefully controlled disease-model experiments.

• Thioguanine: From Mechanism to Assay Meaning

  2026-09-09

  Thioguanine and 6-thioguanine are often discussed as therapeutic or experimental agents, but their interpretation depends strongly on assay context. This guide connects HGPRT bioactivation, DNMT1 inhibition, antiviral and antitumor evidence, and the often-misunderstood use of 6-thioguanine as a mutation-selection reagent.

• Allicin Enhances SeMNPV Susceptibility in S. exigua

  2026-09-09

  A 2025 Journal of Pest Science study shows that allicin increases the mortality of Spodoptera exigua larvae infected with SeMNPV and identifies cytochrome P450 metabolism, particularly CYP340AA1, as a mechanistic component. The work combines insect-virus bioassays, RNA sequencing, and RNA interference to connect a plant-derived metabolite with altered entomovirus susceptibility.

• NHE1, Olfr2, and Macrophage-Driven Atherosclerosis

  2026-09-08

  This study identifies NHE1 as a downstream effector of octanal–Olfr2 signaling in macrophages, linking calcium-dependent ROS production with NLRP3-associated inflammation and atherosclerotic plaque progression. Using ApoE−/− mice and RAW264.7 macrophages, the authors combine in vivo disease modeling, pharmacological inhibition, RNA interference, and calcium chelation to establish a mechanistic framework for this pathway.

• KR-12–Cu(II) Binding: Insights from a 2024 Study

  2026-09-08

  The 2024 Dalton Transactions study combines GFN2-xTB/ALPB calculations with potentiometric titration and isothermal titration calorimetry to clarify how KR-12 interacts with Cu(II). Its central finding is that favorable binding relies largely on peptide backbone oxygen atoms, while aspartate and Arg29 contribute important residue-level organization that experimental measurements alone cannot fully resolve.

• Deferoxamine Mesylate for Ferroptosis Research

  2026-09-07

  Deferoxamine mesylate gives researchers a practical way to reduce labile iron, interrogate ferroptosis, and separate iron-dependent oxidative injury from broader stress responses. Its water solubility and activity in hypoxia, cancer, wound-healing, and tissue-protection models support flexible, mechanism-led assay design.

• FH1: Building More Predictive iHep Assays

  2026-09-07

  FH1 small molecule supports a maturity-first strategy for iPS-derived hepatocyte assays. This article connects functional hepatocyte qualification with the practical design of liver gene-regulation models, including light-controlled translational systems.

• n-Dodecyl-β-D-maltoside for Assay Reliability

  2026-09-05

  This scenario-driven guide explains how n-Dodecyl-β-D-maltoside, SKU C4421, can improve membrane-protein workflows while preventing detergent carryover from confounding cell viability, proliferation, or cytotoxicity assays. It provides practical compatibility controls, preparation parameters, interpretation guidance, and vendor-selection criteria.

• Radioiodinated Balsalazide for Ulcerative Colitis Imaging

  2026-09-04

  The reference study developed and evaluated radioiodinated balsalazide as a colon-directed tracer for imaging ulcerative colitis in mice. Its main contribution is the combination of optimized iodine labeling, 24-hour stability assessment, and comparative biodistribution, with substantially greater tracer accumulation reported in ulcerated than normal colon.

• Pifithrin-α (PFTα) for Reliable p53 Assays

  2026-09-04

  Learn how Pifithrin-α (PFTα), SKU A4206, can help separate p53-dependent apoptosis, growth arrest, and ferroptosis in cell-based experiments. This scenario-driven guide covers assay design, solvent handling, interpretation, and practical reagent-selection criteria.

• Gastrin I: Designing Better Organoid Assays

  2026-09-03

  Gastrin I is more than a stimulus for gastric acid secretion: it can serve as a mechanistic perturbation for testing receptor competence, epithelial polarity, and assay validity. This guide connects the human Gastrin I peptide with new hiPSC-derived organoid methods while clearly defining their translational limits.

• Lactate–GPR81–RAC1 Control of Glucose Uptake

  2026-09-03

  A 2026 Cell Research study identifies lactate as an insulin-independent regulator of skeletal-muscle glucose uptake. Its central finding is that lactate activates GPR81, recruits FARP1, and stimulates RAC1-dependent GLUT4 translocation, linking exercise-associated metabolism to glucose control.

• Microfluidized Microgels for Oral Colon Cancer Therapy

  2026-09-02

  The reference study developed dextran microgels that sequentially deliver cisplatin- and SPION-loaded lipid nanoparticles to orthotopic colon tumors after oral administration. Colon-associated enzymatic release, dextran-mediated retention, folate-receptor targeting, chemotherapy, and magnetothermal treatment were integrated to improve local efficacy while limiting nonspecific gastrointestinal exposure.

• MitMAB for Reproducible Endocytosis Assays

  2026-09-02

  This scenario-based guide explains how MitMAB (SKU B7620) can help researchers separate dynamin-dependent vesicle uptake from nonspecific changes in cell viability, especially in intestinal organoid and extracellular-vesicle workflows. It covers model compatibility, solution handling, controls, interpretation, and practical supplier-selection criteria.

• PD 173074 for FGFR1/VEGFR2 Research

  2026-09-01

  PD 173074 enables controlled interrogation of FGFR1 and VEGFR2 signaling across pancreatic cancer, angiogenesis, and drug-resistance models. This practical guide connects the compound to a pancreatic adenocarcinoma systems study while emphasizing assay design, exposure control, and interpretation limits.

8672 records 6/579 page Previous Next First page 上5页 678910 下5页 Last page